Hemab Therapeutics Holdings, Inc. (COAG)

CIK 2114044 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Hemab Therapeutics Holdings, Inc..

Recent SEC filings

FiledFormAccession number
Aug 14, 2026SCHEDULE 13G0001388325-26-000046
Aug 14, 2026SCHEDULE 13G0000902664-26-003462
Aug 12, 2026SCHEDULE 13G0001562230-26-000124
Aug 11, 202610-Q0001193125-26-344533
Aug 11, 20268-K0001193125-26-343421
Aug 7, 2026SCHEDULE 13G0002005369-26-000041
Aug 6, 2026SCHEDULE 13G0000315066-26-002021
Aug 5, 2026SCHEDULE 13G0001104659-26-090835
Jun 17, 202640001231919-26-000665
May 21, 202610-Q0001193125-26-234386
May 21, 202640001231919-26-000521
May 21, 20268-K0001193125-26-233375
May 14, 202630001193125-26-223979
May 14, 202640001231919-26-000495
May 11, 2026SCHEDULE 13G0001346824-26-000127
May 11, 2026SCHEDULE 13D0001193125-26-216973
May 11, 202640001231919-26-000475
May 11, 20268-K0001193125-26-216699
May 8, 2026SCHEDULE 13G0001172661-26-001639
May 6, 202640001231919-26-000457
May 6, 202640001388325-26-000023
May 4, 2026S-80001193125-26-201820
May 4, 20268-K0001193125-26-203988
May 4, 202640001193125-26-204048
May 4, 202640001193125-26-204041